Findings from the LEAP2MONO study support the regulatory submission of venglustat for treatment of type 3 Gaucher disease.

Paul McNeill, P.Geo., VP Exploration of NexGold, is considered a “Qualified Person” for the purposes of National Instrument ...

As AI becomes embedded in finance operations, especially through agentic systems that act on behalf of organizations, the ...

Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains") is pleased to announce that crews have been mobilized to complete a 1650m, three-hole diamond drilling program at its 100% ...

NexGold Mining Corp. TSXV: NEXG; OTCQX: NXGCF) ("NexGold" or the "Company") is pleased to provide initial results from the ...

Former Artsakh official reveals gaps in Armenia’s housing assistance, with most refugees forced into the expensive secondhand ...

Under the patronage of His Highness Sheikh Dr. Sultan bin Muhammad Al Qasimi, Supreme Council Member and Ruler of Sharjah, ...

Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...

SHARJAH, 2nd February, 2026 (WAM) -- Under the patronage of His Highness Sheikh Dr. Sultan bin Muhammad Al Qasimi, Supreme Council Member and Ruler of Sharjah, the 5th Sharjah International Summit on ...

Chamnong, MD, Ophthalmologist and Specialist in Cataract and Vitreoretinal Surgery, has proudly achieved “Excellent” ...

Glencore’s latest price target has shifted, and that change puts a fresh spotlight on how investors are thinking about the stock today. With the narrative around the company evolving, the new target ...